StockVS

NASDAQ · Scientific & Technical Instruments · USD

Mesa Laboratories, Inc. (MLAB) Stock Analysis

Mesa Laboratories, Inc. (MLAB) is a Scientific & Technical Instruments stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

MLAB

$129.20

+$4.04 (+3.23%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MLAB with… →

MLAB Key Statistics

As of Oct 21, 2026
Trading
Open
$124.21
Previous Close
$125.16
Day's Range
123.76–129.78
52-Week Range
69.51–144.35
Volume
84.17K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.05
Valuation
Market Cap
$722.99M
P/E Ratio
152.00
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
12.58
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.90
EPS (ttm)Profit attributable to each share over the last twelve months.
0.85
Financials (FY)
Revenue (FY)
$249.13M+3.38%
Net Income (FY)
$6.71M
Profit marginThe share of revenue left as profit after all costs and taxes.
1.92%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
5.60M
1-Year Return
+64.57%
Dividend and dates
Dividend
$0.64+0.51%
Ex-Dividend Date
November 30, 2026
Earnings Date
November 9, 2026
Avg Volume
133.07K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, MLAB closed at $129.20, +64.57% over 1 year.

Mesa Laboratories, Inc. (MLAB) has a market capitalization of $722.99M.

In fiscal 2025, MLAB reported revenue of $249.13M.

MLAB Stock Return by Calendar Year

Mesa Laboratories, Inc. (MLAB) 10-year return: what $10,000 became

1 year
$10,000 $16,457
+64.57%
5 years
$10,000 $4,370
−56.30%
10 years
$10,000 $11,082
+10.82%

If you had invested $10,000 in Mesa Laboratories, Inc. (MLAB) 10 years ago, at the close on October 21, 2016, it would have been worth $11,082 at the close on October 21, 2026: +10.82% in total, +1.03% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+65.12%
2025−40.05%
2024+26.56%
2023−36.65%
2022−49.18%
2021+14.73%
2020+15.22%
2019+20.01%
2018+68.27%
2017+1.74%
2016 (partial year)+18.67%

As of October 21, 2026.

MLAB Revenue and Earnings by Fiscal Year

FY ends March
Fiscal yearRevenueNet incomeNet margin
2025$249.13M$6.71M2.7%
2024$240.98M−$1.97M−0.8%
2023$216.19M−$254.25M−117.6%
2022$219.08M$930.00K0.4%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$249.13M$158.27M$18.51M$6.71M2.7%
2024$240.98M$150.87M$16.34M−$1.97M−0.8%
2023$216.19M$133.25M$2.46M−$254.25M−117.6%
2022$219.08M$133.69M$3.32M$930.00K0.4%

Annual figures as reported, in the company's reporting currency. As of March 31, 2026.

MLAB Dividend History

$0.64+0.0% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$0.483—
2025$0.644+0.0%
2024$0.644+0.0%
2023$0.644+0.0%
YearDividends per sharePaymentsChange
2026 (partial year)$0.483—
2025$0.644+0.0%
2024$0.644+0.0%
2023$0.644+0.0%
2022$0.644+0.0%
2021$0.644+0.0%
2020$0.644+0.0%
2019$0.644+0.0%
2018$0.644+0.0%
2017$0.644+300.0%
2016$0.161—

Most recent payment: $0.16 per share, ex-dividend August 31, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

MLAB Valuation vs Scientific & Technical Instruments Median

Median of 33 stocks
MetricMLABScientific & Technical Instruments medianvs median
P/E152.0038.813.9x the median
P/S ratio2.904.5837% below
Profit margin1.92%11.31%9.4 pts below

Medians across 33 Scientific & Technical Instruments stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Mesa Laboratories, Inc. (MLAB) at $722.99M. It is classified in the Scientific & Technical Instruments industry, within the Technology sector. The company reports 717 employees.

The most recent close on file for MLAB is $129.20, dated October 21, 2026. That is +$4.04 (+3.23%) against the previous close. The 52-week range on file runs from $69.51 to $144.35. The latest close sits 85.87% above that 52-week low.

Financial Health

In fiscal 2025, Mesa Laboratories, Inc. reported revenue of $249.13M. Against the prior fiscal year total of $240.98M, that is a change of +3.38%. The same year closed with net income of $6.71M. The reported profit margin is 1.92%. That is 9.4 percentage points below the Scientific & Technical Instruments median of 11.31%. Trailing earnings per share are 0.85.

Across the 4 fiscal years on file, revenue moves from $219.08M in 2022 to $249.13M in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

MLAB trades at a trailing price-to-earnings ratio of 152. That is 3.9 times the Scientific & Technical Instruments median of 38.81. The forward P/E on file is 12.58. The price-to-sales ratio is 2.9. On price-to-sales that is 36.82% below the Scientific & Technical Instruments median of 4.58. 33 Scientific & Technical Instruments companies report these metrics, and the medians quoted come from that group.

The reported beta is 1.05. Daily returns over the trailing 10 years annualize to a volatility of 43.99%. The trailing one-year total return is +64.57%. Measured over 10 years, that is +1.03% a year compounded.

Growth & Income

Shareholders receive a dividend, yielding 0.51% on the latest price. At the indicated rate that is $0.64 a share a year. The ex-dividend date on file is November 30, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $0.48 a share. The year before, 2025, totalled $0.64 a share.

The strongest complete calendar year on file is 2018 at +68.27%; the weakest is 2022 at −49.18%. Of the 9 complete calendar years on file, 6 finished higher. 2026 is still running; the total return is +65.12% year to date.

Peer Comparison

Mesa Laboratories, Inc. (MLAB) operates in the Scientific & Technical Instruments industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Mesa Laboratories, Inc. MLAB $722.99M 152.0
Keysight Technologies, Inc. KEYS $58.11B 46.2
Garmin Ltd. GRMN $56.15B 30.0
Coherent Corp. COHR $46.78B 57.7

The Scientific & Technical Instruments industry average P/E ratio is 38.8x. Mesa Laboratories, Inc. trades at a P/E of 152.0.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Scientific & Technical Instruments Stocks

View all Scientific & Technical Instruments stocks →

Popular Technology Stocks

View all Technology stocks →

About Mesa Laboratories, Inc.

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Visit website →